OP-3 ASSESSING TREATMENT ELIGIBILITY EXPANSION UNDER THE 2024 WHO GUIDELINES FOR CHRONIC HEPATITIS B

OP-3 ASSESSING TREATMENT ELIGIBILITY EXPANSION UNDER THE 2024 WHO GUIDELINES FOR CHRONIC HEPATITIS B

Conflict of interest: No Introduction and Objectives: The 2024 WHO guidelines for chronic hepatitis B (CHB) aim to expand and simplify treatment eligibility, but these criteria have not been assessed. We aimed to estimate treatment eligibility and uptake according to country-specific guidelines and...

Full description

Saved in:
Bibliographic Details
Main Authors: Manuel Mendizabal, Constanza D Sabate, Esteban Gonzalez Ballerga, Fernando Gruz, Ezequiel Ridruejo, Alejandro Soza, Jaime Poniachik, Grace Vergara, Victoria Mainardi, Gabriel Mezzano, Fernando Bessone, Margarita Anders, Mario G Pessoa, Fernando Cairo, Nelia Hernandez, Melisa Dirchwolf, Hugo Cheinquer, Melina Susana, Luis Rondeau, Grabriel Rifrani, Herman Aguirre, Daniela Chiodi, Carla Enrique, Lucia Navarro, Eugenia Labaronnie, Patricia M Zitelli, Alexandre de Araujo, Antonella Olivetti, Daniela Simian, Diego Giunta, Marcelo Silva, Sebastian Marciano
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268124003843
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S1665268124003843

Similar Items